Clinical TopicsNewsWeb Exclusives

FDA approves Raplixa to help control bleeding during surgery

Share

On April 30, the U.S. Food and Drug Administration (FDA) approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency. Raplixa is used to help control intraoperative bleeding. Read more.

The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What are the key elements to consider when creating a successful initial prompt for AI in nursing education?

More Perspectives